UNSPSC 51441706: Diatrizoate/iodipamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DX102. This VA Drug Class (DX102) classifies this compound as belonging to the group IONIC CONTRAST MEDIA.

UNSPSC 51441706 Diatrizoate/iodipamide is a Commodity code with minimal recent state and local procurement activity tied to its nominal scope. The two recent opportunities tagged under this code do not represent actual purchasing of diatrizoate or iodipamide contrast media. Broward County Aviation Department posted an RFI on June 25, 2026 (responses due July 28, 2026) for maintenance services on Rapiscan X-ray inspection systems — a sole-source designation challenge for highly specialized equipment repair and inspection work. Pasco County, Florida solicited vendors on June 3, 2026 (proposals due June 26, 2026) for large copper sulfate crystals and liquid copper sulfate on an as-needed basis under an indefinite-quantity arrangement. Neither solicitation involves contrast media or the pharmaceutical/medical imaging products the code nominally describes.

State and local government procurement under this code shows no detectable recent activity aligned with diatrizoate or iodipamide supply. The two opportunities in the recent block — one for X-ray system maintenance and one for industrial copper sulfate — appear to be miscoded or unrelated to contrast-media procurement. Without additional recent opportunities demonstrating actual demand for diatrizoate/iodipamide products from state and local health departments, hospitals, or imaging centers, this code does not present a clear business development signal for vendors in the contrast-media space.